Clinical Trials

Phase 3 Active not recruiting

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT04214067 2026-03-18

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

164 enrolled

Sarcoma

Carcinosarcoma

NCT00525720 2026-03-09

Brachytherapy for Prostatic Carcinoma Patients

300 enrolled

Prostatic Neoplasms

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT05320406 2026-02-12

REVELUTION

94 enrolled 13 charts

Prostatic Neoplasms

NCT04395079 2026-02-09

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

Phase 1/2 Active not recruiting

9 enrolled

Metastatic Malignant Female Reproductive System Neoplasm

NCT03543189 2026-01-29

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

44 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

10 enrolled

Endometrial Neoplasms

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Sarcoma

Rhabdomyosarcoma

NCT02595879 2025-11-13

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

21 enrolled 22 charts

Uterine Cervical Neoplasms

NCT05100472 2025-11-04

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT03634267 2025-10-14

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

26 enrolled

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT04253483 2025-09-17

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

14 enrolled

Prostatic Neoplasms

NCT01655836 2025-09-11

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

42 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04634877 2025-06-09

KEYNOTE-B21

990 enrolled

Phase NA Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05994300 2025-06-08

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

30 enrolled

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Radiation Injuries

NCT02346253 2025-04-03

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

146 enrolled